Search Results 881-890 of 16679 for Ureaplasma urealyticum

  1. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  2. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  3. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Infection, Bone metastasis, Pneumothorax, Pleural effusion, Renal cell carcinoma. Show more areas of focus for John J. Schmitz, M.D. ...

  4. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  5. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Infection, Bone metastasis, Pneumothorax, Pleural effusion, Renal cell carcinoma. Show more areas of focus for John J. Schmitz, M.D. ...

  6. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  7. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  8. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  9. Primary Care in Florida - Doctors - Mayo Clinic

    Learn about primary care services, including family medicine and community internal medicine at several locations and how to find a doctor and make an ...

  10. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    ... infection, etc. Demonstration of intolerance requires no minimum dose or duration of use. Note: Non-bio-IR subjects who have received prior biologic for up ...